Total Payments
$3,050
2024 Payments
$13.66
Companies
16
Transactions
223
Medicare Patients
981
Medicare Billing
$56,946
Payment Breakdown by Category
Food & Beverage$3,050 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,050 | 223 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $515.45 | 43 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $427.89 | 19 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $417.12 | 37 | $0 (2022) |
| ABBVIE INC. | $403.31 | 31 | $0 (2023) |
| Lilly USA, LLC | $252.60 | 19 | $0 (2022) |
| Novo Nordisk Inc | $234.24 | 21 | $0 (2022) |
| Astellas Pharma US Inc | $162.82 | 11 | $0 (2024) |
| Amarin Pharma Inc. | $120.06 | 7 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $119.55 | 8 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $106.68 | 8 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.66 | 1 | Astellas Pharma US Inc ($13.66) |
| 2023 | $185.86 | 12 | Astellas Pharma US Inc ($135.38) |
| 2022 | $1,695 | 126 | GlaxoSmithKline, LLC. ($323.31) |
| 2021 | $1,155 | 84 | Takeda Pharmaceuticals U.S.A., Inc. ($248.69) |
All Payment Transactions
223 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Biological | ||||||
| 12/11/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: Biological | ||||||
| 11/01/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $7.57 | General |
| Category: Biological | ||||||
| 08/25/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $6.06 | General |
| Category: Biological | ||||||
| 08/23/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Biological | ||||||
| 08/22/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Biological | ||||||
| 04/21/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Urology | ||||||
| 03/21/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Urology | ||||||
| 02/21/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Urology | ||||||
| 01/27/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: RESPIRATORY | ||||||
| 01/24/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Urology | ||||||
| 01/18/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: RESPIRATORY | ||||||
| 12/20/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.76 | General |
| Category: RESPIRATORY | ||||||
| 12/20/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.16 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Diabetes | ||||||
| 12/06/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $0.52 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Diabetes | ||||||
| 12/01/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/29/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2022 | PFIZER INC. | ELIQUIS (Drug), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/18/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 828 | 1,201 | $151,095 | $38,520 |
| 2022 | 2 | 94 | 192 | $45,516 | $13,107 |
| 2021 | 2 | 59 | 71 | $16,586 | $5,319 |
Total Patients
981
Total Services
1,464
Medicare Billing
$56,946
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 156 | 167 | $50,558 | $12,097 | 23.9% |
| 87637 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | Office | 2023 | 40 | 40 | $14,356 | $5,451 | 38.0% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 53 | 53 | $12,720 | $4,976 | 39.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $18,170 | $4,362 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 52 | $11,106 | $2,618 | 23.6% |
| 87634 | Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique | Office | 2023 | 34 | 34 | $5,698 | $2,339 | 41.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 59 | 60 | $14,600 | $2,077 | 14.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $5,579 | $1,516 | 27.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 101 | 117 | $4,005 | $950.17 | 23.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 27 | 29 | $2,320 | $567.58 | 24.5% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 34 | 34 | $2,634 | $550.80 | 20.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 23 | 25 | $2,036 | $258.75 | 12.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 27 | 29 | $232.00 | $227.36 | 98.0% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 26 | 26 | $970.00 | $225.97 | 23.3% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 35 | 36 | $638.00 | $178.05 | 27.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 28 | 29 | $1,599 | $63.80 | 4.0% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 22 | 89 | $3,560 | $31.89 | 0.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 45 | 314 | $314.00 | $28.07 | 8.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 135 | $35,370 | $10,016 | 28.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 57 | $10,146 | $3,091 | 30.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 37 | 47 | $12,314 | $3,938 | 32.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 24 | $4,272 | $1,381 | 32.3% |
About Sarah Dailey, PA-C
Sarah Dailey, PA-C is a Physician Assistant healthcare provider based in Mount Pleasant, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/13/2020. The National Provider Identifier (NPI) number assigned to this provider is 1518507995.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sarah Dailey, PA-C has received a total of $3,050 in payments from pharmaceutical and medical device companies, with $13.66 received in 2024. These payments were reported across 223 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($3,050).
As a Medicare-enrolled provider, Dailey has provided services to 981 Medicare beneficiaries, totaling 1,464 services with total Medicare billing of $56,946. Data is available for 3 years (2021–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Mount Pleasant, TX
- Active Since 01/13/2020
- Last Updated 11/17/2025
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1518507995
Products in Payments
- TRELEGY ELLIPTA (Drug) $431.83
- TRINTELLIX (Drug) $417.12
- FARXIGA (Drug) $239.27
- QULIPTA (Drug) $192.57
- BREZTRI (Drug) $146.99
- Vascepa (Drug) $120.06
- UBRELVY (Drug) $115.25
- ELIQUIS (Drug) $102.37
- VRAYLAR (Drug) $95.49
- Myrbetriq (Drug) $91.70
- EMGALITY (Drug) $89.62
- TRULICITY (Drug) $88.20
- Rybelsus (Drug) $83.10
- TOUJEO (Biological) $79.52
- MOUNJARO (Drug) $74.78
- Wegovy (Drug) $72.88
- Veozah (Drug) $71.12
- Yupelri (Drug) $55.89
- JARDIANCE (Drug) $54.06
- BELSOMRA (Drug) $52.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Mount Pleasant
Megan Cundiff, Pa-C, PA-C
Physician Assistant — Payments: $13,175
Physician Assistant $13,175
Cameron Oswald, Pa, PA
Physician Assistant — Payments: $7,474
Physician Assistant $7,474
Alexa Crane, Pa-C, PA-C
Physician Assistant — Payments: $4,315
Physician Assistant $4,315
Jade Kimble, Pa, PA
Physician Assistant — Payments: $3,976
Physician Assistant $3,976
Miss. Rebecca Repaire, Pa-C, PA-C
Physician Assistant — Payments: $2,999
Physician Assistant $2,999
Megan Harrington
Physician Assistant — Payments: $2,743
Physician Assistant $2,743